Albert Cha
Chairman at ASCENDIS PHARMA A/S
Net worth: 53 540 $ as of 2024-04-29
Network origin in Albert Cha first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Stanford University
339
| College/University | Other Consumer Services | 339 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington.
105
| Subsidiary | Investment Managers | 105 |
| Public Company | Pharmaceuticals: Major | 32 | |
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California.
30
| Private Company | Investment Managers | 30 |
| Public Company | Pharmaceuticals: Major | 24 | |
BioForm Medical, Inc.
 BioForm Medical, Inc. Medical SpecialtiesHealth Technology BioForm Medical, Inc. is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient's appearance. Their core product is Radiesse dermal filler, an injectable dermal filler designed to provide aesthetic improvement for patients. The company also offers Radiesse Voice and Radiesse Voice Gel for vocal fold insufficiency and Coaptite as a treatment for women who have stress urinary incontinence. BioForm Medical was founded in 1999 and is headquartered in San Mateo, CA.
23
| Extinct | Medical Specialties | 23 |
| Extinct | Biotechnology | 20 | |
Carbylan Therapeutics, Inc.
 Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA.
13
| Extinct | Pharmaceuticals: Major | 13 |
| Subsidiary | Pharmaceuticals: Major | 13 | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
| Extinct | Pharmaceuticals: Major | 10 | |
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT.
9
| Extinct | Pharmaceuticals: Major | 9 |
| Public Company | Pharmaceuticals: Major | 7 | |
| Extinct | Medical Specialties | 5 | |
Ceptaris Therapeutics, Inc.
 Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA.
2
| Subsidiary | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Albert Cha via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Founder Corporate Secretary General Counsel Founder Director/Board Member | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree Masters Business Admin | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Director of Finance/CFO Director of Finance/CFO | |
| University of California, Berkeley | College/University | Doctorate Degree Masters Business Admin Graduate Degree Undergraduate Degree | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree Graduate Degree | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Indiana University | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Public Communications Contact | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Secretary | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| Middlebury College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
Ascension Orthopedics, Inc.
 Ascension Orthopedics, Inc. Medical SpecialtiesHealth Technology Ascension Orthopedics, Inc. designs, develops and markets orthopedic implants and devices. The company was founded by Jerome J. Klawitter in 1996 and is headquartered in Overland Park, KS. | Medical Specialties | Director/Board Member Chairman | |
Informed Medical Communications, Inc.
 Informed Medical Communications, Inc. Miscellaneous Commercial ServicesCommercial Services Informed Medical Communications, Inc. provides medical forums, training services, and integrated medical communications. It is an interactive medical marketing group of companies providing services to the biopharmaceutical industry. The firm offers a communications training service for elite skill development for sales organizations and speaker bureaus. The company was founded in 2005 and is headquartered in Edison, NJ. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Director of Finance/CFO Comptroller/Controller/Auditor | |
| Harvard Medical School | College/University | Corporate Officer/Principal Graduate Degree | |
| Boston University | College/University | Doctorate Degree Graduate Degree | |
| University of British Columbia | College/University | Graduate Degree Undergraduate Degree | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member | |
FlowCardia, Inc.
 FlowCardia, Inc. Medical SpecialtiesHealth Technology FlowCardia, Inc. designs, develops and manufactures endovascular devices. It offers flowmate Injector to optimize the performance of crosser cto recanalization and crosser catheter, a minimally-invasive endovascular device. The firm also provides portfolio of catheter-based technologies to facilitate guidewire crossing of totally occluded coronary and peripheral arteries. The company was founded by Henry Nita and Erik T. Engelson in 2001 and is headquartered in Sunnyvale, CA. | Medical Specialties | Chairman Director/Board Member | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Alnara Pharmaceuticals, Inc.
 Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder Director/Board Member | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Young Men's Christian Association of Greater Boston, Inc.
 Young Men's Christian Association of Greater Boston, Inc. Miscellaneous Commercial ServicesCommercial Services The YMCA of Greater Boston, Inc. provides social services. The firm offers youth development, healthy living and social responsibility services. It conducts pre-K, youth, teen, adult., family programs and provides early education care services. The company was founded in 1851 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Oregon | College/University | Undergraduate Degree Undergraduate Degree | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Graduate Degree | |
EPTAM Precision Solutions, Inc.
 EPTAM Precision Solutions, Inc. Metal FabricationProducer Manufacturing EPTAM Precision Solutions engages in the provision of precision manufacturing solutions in both plastics and metals to medical, aerospace and defense, and semiconductor industries. It focuses on machining and injection molding applications. The firm offers fabricating capabilities, including plastic machining, turning, plastic milling, plastic routing, sawing, laser marking, and drilling. The company was founded in 1981 and is headquartered in Northfield, NH. | Metal Fabrication | Director/Board Member Director/Board Member | |
PricewaterhouseCoopers (Denmark)
 PricewaterhouseCoopers (Denmark) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Denmark) is a company based in Hellerup, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal Chairman | |
| The University of Manchester | College/University | Doctorate Degree Doctorate Degree | |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Information Technology ServicesTechnology Services Sudo Biosciences, Inc. is a biopharmaceutical company that focuses on designing and developing innovative medicines to improve the lives of patients. Sudo Biosciences is based in Menlo Park, CA, and has operations in other locations. The company's primary focus is on developing treatments that target the tyrosine kinase 2 (TYK2) pseudokinase domain, which is a crucial mediator in cytokine signaling pathways that have been associated with various immune-mediated inflammatory conditions. The CEO of the company is Scott A. Byrd. | Information Technology Services | Director/Board Member Director/Board Member | |
CDR-Life Inc.
 CDR-Life Inc. BiotechnologyHealth Technology CDR-Life Inc. is a Swiss biotherapeutics company that develops novel immunotherapies to target the power of the immune system specifically to tumor cells. CDR-Life is based in Schlieren, Switzerland, and was founded in 2017 by Leonardo Borras, Christian Leisner, Dominik Escher, Rouven Bingel-Erlenmeyer, and Konstantin von Schulthess. The company's proprietary antibody platform targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high affinity and specificity, which allows them to develop a pipeline of first-in-class therapeutics across a broad range of solid tumors. The company is backed by leading cross-Atlantic investors and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat macular degeneration. Christian Leisner has been the CEO since 2017. | Biotechnology | Director/Board Member Director/Board Member | |
Afmedica, Inc.
 Afmedica, Inc. Pharmaceuticals: MajorHealth Technology Afmedica, Inc. develops medical and drug products. It develops perivascular technology using the drug rapamycin to treat peripheral vascular disease, coronary artery disease, and end stage renal disease. The company was founded in 2002 and is located in Kalamazoo, MI. | Pharmaceuticals: Major | Chief Executive Officer Founder | |
| BIOHAVEN LTD. | Pharmaceuticals: Major | Compliance Officer Comptroller/Controller/Auditor |
Statistics
International
| United States | 38 |
| Denmark | 6 |
| United Kingdom | 4 |
| Cayman Islands | 2 |
| China | 2 |
Sectoral
| Health Technology | 24 |
| Consumer Services | 19 |
| Commercial Services | 7 |
| Finance | 2 |
| Producer Manufacturing | 2 |
Operational
| Director/Board Member | 471 |
| Corporate Officer/Principal | 195 |
| Independent Dir/Board Member | 111 |
| Chairman | 94 |
| Undergraduate Degree | 80 |
Most connected contacts
| Insiders | |
|---|---|
| James Topper | 49 |
| Jack Nielsen | 38 |
| Arnold Lewis Oronsky | 35 |
| Richard H. Aldrich | 31 |
| Donald Parfet | 31 |
| Alan Frazier | 31 |
| Nathan Every | 26 |
| Nader Naini | 26 |
| Lars Holtug | 26 |
| David Topper | 25 |
| Rafaèle Elisabeth Tordjman | 23 |
| Michael Wolff Jensen | 23 |
| Mina Sooch | 23 |
| Brian Pereira | 23 |
| Gaurav Aggarwal | 21 |
- Stock Market
- Insiders
- Albert Cha
- Company connections